U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07813793) titled 'Role of Triglyceride-Glucose Index and Inflammatory Biomarkers as Prognostic Tools for Progression of Diabetic Nephropathy' on Sept. 05.
Brief Summary: This study aims to evaluate the prognostic value of the Triglyceride-Glucose (TyG) index alongside inflammatory biomarkers in predicting the progression of diabetic nephropathy, exploring their correlation with disease severity to identify accessible, cost-effective markers for early risk stratification and clinical monitoring in diabetic patients.
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Diabetes Mellitus
Diabetic Nephropathy
Recruitment Status: NOT_YET_R...